These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 31755692)
1. Magnetic Targeting of mTHPC To Improve the Selectivity and Efficiency of Photodynamic Therapy. Haimov-Talmoud E; Harel Y; Schori H; Motiei M; Atkins A; Popovtzer R; Lellouche JP; Shefi O ACS Appl Mater Interfaces; 2019 Dec; 11(49):45368-45380. PubMed ID: 31755692 [TBL] [Abstract][Full Text] [Related]
2. meso-Tetrahydroxyphenylchlorin-Conjugated Gold Nanoparticles as a Tool To Improve Photodynamic Therapy. Haimov E; Weitman H; Polani S; Schori H; Zitoun D; Shefi O ACS Appl Mater Interfaces; 2018 Jan; 10(3):2319-2327. PubMed ID: 29298037 [TBL] [Abstract][Full Text] [Related]
3. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo. Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168 [TBL] [Abstract][Full Text] [Related]
4. Nanoparticle albumin-bound mTHPC for photodynamic therapy: Preparation and comprehensive characterization of a promising drug delivery system. Stein NC; Mulac D; Fabian J; Herrmann FC; Langer K Int J Pharm; 2020 May; 582():119347. PubMed ID: 32315751 [TBL] [Abstract][Full Text] [Related]
5. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response. Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792 [TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of mTHPC-loaded solid lipid nanoparticles for photodynamic therapy. Navarro FP; Creusat G; Frochot C; Moussaron A; Verhille M; Vanderesse R; Thomann JS; Boisseau P; Texier I; Couffin AC; Barberi-Heyob M J Photochem Photobiol B; 2014 Jan; 130():161-9. PubMed ID: 24333764 [TBL] [Abstract][Full Text] [Related]
7. Dextran-Benzoporphyrin Derivative (BPD) Coated Superparamagnetic Iron Oxide Nanoparticle (SPION) Micelles for T Yan L; Luo L; Amirshaghaghi A; Miller J; Meng C; You T; Busch TM; Tsourkas A; Cheng Z Bioconjug Chem; 2019 Nov; 30(11):2974-2981. PubMed ID: 31661959 [TBL] [Abstract][Full Text] [Related]
8. Wavelength dependent photo-cytotoxicity to ovarian carcinoma cells using temoporfin loaded tetraether liposomes as efficient drug delivery system. Ali S; Amin MU; Ali MY; Tariq I; Pinnapireddy SR; Duse L; Goergen N; Wölk C; Hause G; Jedelská J; Schäfer J; Bakowsky U Eur J Pharm Biopharm; 2020 May; 150():50-65. PubMed ID: 32151728 [TBL] [Abstract][Full Text] [Related]
9. EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy. Liu Y; Scrivano L; Peterson JD; Fens MHAM; Hernández IB; Mesquita B; Toraño JS; Hennink WE; van Nostrum CF; Oliveira S Mol Pharm; 2020 Apr; 17(4):1276-1292. PubMed ID: 32142290 [No Abstract] [Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements. Glanzmann T; Forrer M; Blant SA; Woodtli A; Grosjean P; Braichotte D; van den Bergh H; Monnier P; Wagnières G J Photochem Photobiol B; 2000 Aug; 57(1):22-32. PubMed ID: 11100834 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of mTHPC-loaded PLGA nanoparticles for in vitro photodynamic therapy on C6 glioma cell line. Bœuf-Muraille G; Rigaux G; Callewaert M; Zambrano N; Van Gulick L; Roullin VG; Terryn C; Andry MC; Chuburu F; Dukic S; Molinari M Photodiagnosis Photodyn Ther; 2019 Mar; 25():448-455. PubMed ID: 30708089 [TBL] [Abstract][Full Text] [Related]
12. Comparative sensitivity of microvascular endothelial cells, fibroblasts and tumor cells after in vitro photodynamic therapy with meso-tetra-hydroxyphenyl-chlorin. Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA Photochem Photobiol; 2004; 80(2):236-41. PubMed ID: 15362947 [TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic treatment (Bevacizumab) improves the responsiveness of photodynamic therapy in colorectal cancer. Peng CL; Lin HC; Chiang WL; Shih YH; Chiang PF; Luo TY; Cheng CC; Shieh MJ Photodiagnosis Photodyn Ther; 2018 Sep; 23():111-118. PubMed ID: 29894822 [TBL] [Abstract][Full Text] [Related]
14. MnFe Ding B; Shao S; Xiao H; Sun C; Cai X; Jiang F; Zhao X; Ma P; Lin J Nanoscale; 2019 Aug; 11(31):14654-14667. PubMed ID: 31355836 [TBL] [Abstract][Full Text] [Related]
15. Preclinical comparison of mTHPC and verteporfin for intracavitary photodynamic therapy of malignant pleural mesothelioma. Opitz I; Krueger T; Pan Y; Altermatt HJ; Wagnières G; Ris HB Eur Surg Res; 2006; 38(3):333-9. PubMed ID: 16785733 [TBL] [Abstract][Full Text] [Related]
16. Immune Reprogramming Precision Photodynamic Therapy of Peritoneal Metastasis by Scalable Stem-Cell-Derived Extracellular Vesicles. Pinto A; Marangon I; Méreaux J; Nicolás-Boluda A; Lavieu G; Wilhelm C; Sarda-Mantel L; Silva AKA; Pocard M; Gazeau F ACS Nano; 2021 Feb; 15(2):3251-3263. PubMed ID: 33481565 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers. Ma L; Moan J; Berg K Int J Cancer; 1994 Jun; 57(6):883-8. PubMed ID: 8206681 [TBL] [Abstract][Full Text] [Related]
18. Photodynamic dose does not correlate with long-term tumor response to mTHPC-PDT performed at several drug-light intervals. Wang KK; Mitra S; Foster TH Med Phys; 2008 Aug; 35(8):3518-26. PubMed ID: 18777912 [TBL] [Abstract][Full Text] [Related]
19. Correlation of photodynamic activity and fluorescence signaling for free and pegylated mTHPC in mesothelioma xenografts. Tran N; Krueger T; Pan Y; Yan H; Cheng C; Altermatt HJ; Ballini JP; Borle F; Ris HB; Andrejevic-Blant S Lasers Surg Med; 2007 Mar; 39(3):237-44. PubMed ID: 17345623 [TBL] [Abstract][Full Text] [Related]
20. Photochemical internalization (PCI)-mediated enhancement of bleomycin cytotoxicity by liposomal mTHPC formulations in human head and neck cancer cells. Peng W; Samplonius DF; de Visscher S; Roodenburg JL; Helfrich W; Witjes MJ Lasers Surg Med; 2014 Oct; 46(8):650-8. PubMed ID: 25174329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]